Home > Financial Ratios > SUDARSHAN PHARMA INDUSTRIES

SUDARSHAN PHARMA INDUSTRIES
Core EBITDA Growth

    Back to All Ratios
SUDARSHAN PHARMA INDUSTRIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUDARSHAN PHARMA INDUSTRIES
Please provide your vote to see the results

SUDARSHAN PHARMA INDUSTRIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 66.9760.8138.8850.89-

What is the latest Core EBITDA Growth ratio of SUDARSHAN PHARMA INDUSTRIES ?

The latest Core EBITDA Growth ratio of SUDARSHAN PHARMA INDUSTRIES is 66.97 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202566.97
Mar202460.81
Mar202338.88
Mar202250.89
Mar2021-

How is Core EBITDA Growth of SUDARSHAN PHARMA INDUSTRIES Trending?

Years Core EBITDA Growth % Change
Mar2025 66.97
10.13
Mar2024 60.81
56.40
Mar2023 38.88
-23.60
Mar2022 50.89
0
Mar2021 0 -

Other Financial Ratios of SUDARSHAN PHARMA INDUSTRIES


Compare Core EBITDA Growth ratio of peers of SUDARSHAN PHARMA INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES ₹1,004.0 Cr -4.7% 9.4% 22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUDARSHAN PHARMA INDUSTRIES

-4.7%

9.4%

22.9%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses